Biomx Other Assets vs Total Liab Analysis

PHGE Stock

USD 0.33 0.02 5.71%

Biomx financial indicator trend analysis is way more than just evaluating Biomx Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomx Inc is a good investment. Please check the relationship between Biomx Other Assets and its Total Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Other Assets vs Total Liab

Other Assets vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomx Inc Other Assets account and Total Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Biomx's Other Assets and Total Liab is -0.83. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Total Liab in the same time period over historical financial statements of Biomx Inc, assuming nothing else is changed. The correlation between historical values of Biomx's Other Assets and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Biomx Inc are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Other Assets i.e., Biomx's Other Assets and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.83

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Other Assets

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Biomx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomx Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

At present, Biomx's Enterprise Value is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	35.5M	27.2M	26.8M	22.4M
Research Development	22.7M	16.2M	19.0M	14.7M

Total Operating Expenses Research Development

Biomx fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Net Invested Capital
Total Assets		0.62	0.91	0.87	0.82	0.1	0.97	-0.78	-0.71	0.94	0.89	0.59	-0.17	-0.84	0.91	0.2	0.12	0.5	0.37	0.54	0.89	0.64	0.95	0.63	-0.67	0.9
Short Long Term Debt Total	0.62		0.78	0.89	0.23	0.41	0.52	-0.26	-0.89	0.55	0.55	0.6	-0.62	-0.83	0.43	0.82	-0.16	0.75	-0.17	0.73	0.8	0.94	0.74	0.78	-0.91	0.42
Other Current Liab	0.91	0.78		0.94	0.64	0.08	0.8	-0.63	-0.78	0.89	0.8	0.62	-0.33	-0.81	0.78	0.52	-0.01	0.63	0.2	0.63	0.88	0.83	0.91	0.71	-0.83	0.76
Total Current Liabilities	0.87	0.89	0.94		0.5	0.34	0.8	-0.52	-0.92	0.82	0.75	0.73	-0.51	-0.92	0.67	0.58	-0.12	0.77	0.03	0.76	0.95	0.84	0.93	0.83	-0.91	0.65
Total Stockholder Equity	0.82	0.23	0.64	0.5		-0.41	0.81	-0.94	-0.2	0.81	0.88	0.04	0.2	-0.47	0.97	-0.17	0.26	-0.07	0.61	-0.05	0.52	0.35	0.69	0.06	-0.24	0.98
Other Liab	0.1	0.41	0.08	0.34	-0.41		0.18	0.43	-0.66	-0.07	-0.21	0.75	-0.41	-0.44	-0.27	0.23	-0.12	0.78	-0.28	0.77	0.43	0.17	0.27	0.72	-0.48	-0.28
Net Tangible Assets	0.97	0.52	0.8	0.8	0.81	0.18		-0.77	-0.67	0.89	0.85	0.58	-0.12	-0.82	0.88	0.02	0.13	0.46	0.41	0.5	0.87	0.5	0.93	0.58	-0.58	0.87
Net Debt	-0.78	-0.26	-0.63	-0.52	-0.94	0.43	-0.77		0.22	-0.87	-0.95	-0.03	0.06	0.56	-0.93	0.06	0.03	0.05	-0.31	0.02	-0.55	-0.38	-0.65	-0.09	0.21	-0.93
Retained Earnings	-0.71	-0.89	-0.78	-0.92	-0.2	-0.66	-0.67	0.22		-0.62	-0.5	-0.87	0.62	0.9	-0.4	-0.61	0.2	-0.94	0.14	-0.92	-0.93	-0.78	-0.83	-0.95	0.93	-0.38
Accounts Payable	0.94	0.55	0.89	0.82	0.81	-0.07	0.89	-0.87	-0.62		0.94	0.48	-0.33	-0.81	0.89	0.22	-0.15	0.43	0.18	0.44	0.85	0.62	0.88	0.53	-0.6	0.87
Cash	0.89	0.55	0.8	0.75	0.88	-0.21	0.85	-0.95	-0.5	0.94		0.25	-0.27	-0.76	0.95	0.22	-0.09	0.22	0.2	0.24	0.75	0.63	0.81	0.35	-0.49	0.94
Non Current Assets Total	0.59	0.6	0.62	0.73	0.04	0.75	0.58	-0.03	-0.87	0.48	0.25		-0.42	-0.73	0.2	0.37	-0.06	0.94	-0.09	0.97	0.77	0.44	0.65	0.97	-0.72	0.18
Non Currrent Assets Other	-0.17	-0.62	-0.33	-0.51	0.2	-0.41	-0.12	0.06	0.62	-0.33	-0.27	-0.42		0.6	0.03	-0.7	0.84	-0.63	0.81	-0.56	-0.53	-0.56	-0.32	-0.56	0.55	0.06
Other Assets	-0.84	-0.83	-0.81	-0.92	-0.47	-0.44	-0.82	0.56	0.9	-0.81	-0.76	-0.73	0.6		-0.64	-0.49	0.21	-0.74	0.12	-0.76	-0.95	-0.75	-0.87	-0.83	0.77	-0.62
Cash And Short Term Investments	0.91	0.43	0.78	0.67	0.97	-0.27	0.88	-0.93	-0.4	0.89	0.95	0.2	0.03	-0.64		0.03	0.19	0.12	0.51	0.15	0.67	0.53	0.81	0.26	-0.42	1.0
Net Receivables	0.2	0.82	0.52	0.58	-0.17	0.23	0.02	0.06	-0.61	0.22	0.22	0.37	-0.7	-0.49	0.03		-0.34	0.59	-0.51	0.56	0.42	0.81	0.3	0.57	-0.68	0.01
Common Stock Total Equity	0.12	-0.16	-0.01	-0.12	0.26	-0.12	0.13	0.03	0.2	-0.15	-0.09	-0.06	0.84	0.21	0.19	-0.34		-0.26	0.81	-0.14	-0.2	-0.16	-0.02	-0.14	0.19	0.21
Common Stock Shares Outstanding	0.5	0.75	0.63	0.77	-0.07	0.78	0.46	0.05	-0.94	0.43	0.22	0.94	-0.63	-0.74	0.12	0.59	-0.26		-0.26	0.98	0.8	0.62	0.65	0.97	-0.86	0.09
Short Term Investments	0.37	-0.17	0.2	0.03	0.61	-0.28	0.41	-0.31	0.14	0.18	0.2	-0.09	0.81	0.12	0.51	-0.51	0.81	-0.26		-0.23	0.03	-0.09	0.28	-0.18	0.04	0.53
Non Current Liabilities Total	0.54	0.73	0.63	0.76	-0.05	0.77	0.5	0.02	-0.92	0.44	0.24	0.97	-0.56	-0.76	0.15	0.56	-0.14	0.98	-0.23		0.77	0.57	0.63	0.99	-0.79	0.12
Capital Surpluse	0.89	0.8	0.88	0.95	0.52	0.43	0.87	-0.55	-0.93	0.85	0.75	0.77	-0.53	-0.95	0.67	0.42	-0.2	0.8	0.03	0.77		0.75	0.96	0.84	-0.87	0.66
Other Current Assets	0.64	0.94	0.83	0.84	0.35	0.17	0.5	-0.38	-0.78	0.62	0.63	0.44	-0.56	-0.75	0.53	0.81	-0.16	0.62	-0.09	0.57	0.75		0.73	0.64	-0.86	0.52
Other Stockholder Equity	0.95	0.74	0.91	0.93	0.69	0.27	0.93	-0.65	-0.83	0.88	0.81	0.65	-0.32	-0.87	0.81	0.3	-0.02	0.65	0.28	0.63	0.96	0.73		0.71	-0.83	0.8
Total Liab	0.63	0.78	0.71	0.83	0.06	0.72	0.58	-0.09	-0.95	0.53	0.35	0.97	-0.56	-0.83	0.26	0.57	-0.14	0.97	-0.18	0.99	0.84	0.64	0.71		-0.84	0.23
Deferred Long Term Liab	-0.67	-0.91	-0.83	-0.91	-0.24	-0.48	-0.58	0.21	0.93	-0.6	-0.49	-0.72	0.55	0.77	-0.42	-0.68	0.19	-0.86	0.04	-0.79	-0.87	-0.86	-0.83	-0.84		-0.4
Net Invested Capital	0.9	0.42	0.76	0.65	0.98	-0.28	0.87	-0.93	-0.38	0.87	0.94	0.18	0.06	-0.62	1.0	0.01	0.21	0.09	0.53	0.12	0.66	0.52	0.8	0.23	-0.4

Click cells to compare fundamentals

Biomx Account Relationship Matchups

Biomx fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	92.1M	70.4M	78.0M	45.5M	58.2M	61.2M
Short Long Term Debt Total	1.2M	5.9M	20.0M	19.4M	15.1M	9.8M
Other Current Liab	2.5M	3.9M	5.5M	1.9M	3.3M	2.9M
Total Current Liabilities	6.2M	7.2M	11.0M	7.9M	11.2M	7.1M
Total Stockholder Equity	84.5M	57.5M	47.5M	21.0M	3.1M	2.9M
Other Liab	585K	701K	215K	2.2M	2.5M	2.6M
Net Tangible Assets	42.8M	84.5M	57.5M	46.0M	52.9M	53.3M
Net Debt	(71.0M)	(30.6M)	(42.1M)	(12.0M)	(772K)	(810.6K)
Retained Earnings	(42.2M)	(72.3M)	(108.5M)	(136.8M)	(163.0M)	(154.8M)
Accounts Payable	3.3M	2.3M	2.8M	820K	1.4M	1.7M
Cash	72.3M	36.5M	62.1M	31.3M	15.9M	15.1M
Non Current Assets Total	7.6M	9.7M	11.4M	8.7M	40.5M	42.6M
Non Currrent Assets Other	70.9M	5K	7.5M	(28.9M)	(26.0M)	(24.7M)
Cash And Short Term Investments	82.3M	56.3M	62.1M	33.3M	15.9M	15.1M
Net Receivables	50K	276K	888K	567K	574K	441.7K
Common Stock Shares Outstanding	5.6M	23.1M	26.0M	29.9M	51.3M	53.9M
Liabilities And Stockholders Equity	92.1M	70.4M	78.0M	45.5M	58.2M	61.2M
Non Current Liabilities Total	1.4M	5.7M	19.4M	16.6M	43.9M	46.1M
Other Current Assets	244K	1.5M	3.5M	2.6M	1.2M	1.5M
Other Stockholder Equity	168.8M	202.0M	156.0M	157.8M	166.0M	143.8M
Total Liab	7.7M	12.9M	30.5M	24.5M	55.1M	57.8M
Net Invested Capital	84.5M	57.5M	61.9M	35.9M	14.3M	13.6M
Total Current Assets	84.5M	60.7M	66.6M	36.9M	17.6M	16.8M
Net Working Capital	78.3M	53.5M	55.6M	28.9M	6.5M	6.1M
Property Plant Equipment	887K	3.0M	6.7M	9.8M	11.3M	11.9M
Property Plant And Equipment Net	3.0M	6.7M	9.8M	8.7M	7.4M	6.7M
Current Deferred Revenue	60K	65K	2.0M	242K	28K	26.6K
Capital Lease Obligations	1.2M	5.9M	5.6M	4.5M	3.9M	3.9M
Property Plant And Equipment Gross	3.0M	6.7M	9.8M	8.7M	10.9M	7.3M
Non Current Liabilities Other	585K	701K	215K	188K	155K	147.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Biomx Inc is a strong investment it is important to analyze Biomx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biomx's future performance. For an informed investment choice regarding Biomx Stock, refer to the following important reports:

How To Invest In Biomx

Details

Is Biomx Stock a good investment?

Details

What is Biomx's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Note that the Biomx Inc information on this page should be used as a complementary analysis to other Biomx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Biomx Stock analysis

When running Biomx's price analysis, check to measure Biomx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomx is operating at the current time. Most of Biomx's value examination focuses on studying past and present price action to predict the probability of Biomx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomx's price. Additionally, you may evaluate how the addition of Biomx to your portfolios can decrease your overall portfolio volatility.

	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated

Is Biomx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.51)

Return On Assets

(0.45)

Return On Equity

(2.17)

The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biomx Other Assets vs Total Liab Analysis

Other Assets vs Total Liab

Other Assets vs Total Liab Correlation Analysis

Correlation Coefficient

Other Assets

Total Liab

Biomx fundamental ratios Correlations

Biomx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biomx fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Biomx Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.99	Non Current Liabilities Total
Net Invested Capital	+ 0.98	Total Stockholder Equity
Non Current Liabilities Total	+ 0.98	Common Stock Shares Outstanding
Net Tangible Assets	+ 0.97	Total Assets
Cash And Short Term Investments	+ 0.97	Total Stockholder Equity

Capital Surpluse	- 0.95	Other Assets
Total Liab	- 0.95	Retained Earnings
Cash	- 0.95	Net Debt
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Net Debt	- 0.94	Total Stockholder Equity
Capital Surpluse	- 0.93	Retained Earnings